Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

Kinetics of nevirapine and its impact on HIV-1 RNA levels in maternal plasma and breast milk over time after perinatal single-dose nevirapine.

Aizire J, McConnell MS, Mudiope P, Mubiru M, Matovu F, Parsons TL, Elbireer A, Nolan M, Janoff EN, Fowler MG.

J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):483-8. doi: 10.1097/QAI.0b013e318246bf9e.

PMID:
22217678
[PubMed - indexed for MEDLINE]
2.

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

Musoke P, Guay LA, Bagenda D, Mirochnick M, Nakabiito C, Fleming T, Elliott T, Horton S, Dransfield K, Pav JW, Murarka A, Allen M, Fowler MG, Mofenson L, Hom D, Mmiro F, Jackson JB.

AIDS. 1999 Mar 11;13(4):479-86.

PMID:
10197376
[PubMed - indexed for MEDLINE]
3.

Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration.

Hudelson SE, McConnell MS, Bagenda D, Piwowar-Manning E, Parsons TL, Nolan ML, Bakaki PM, Thigpen MC, Mubiru M, Fowler MG, Eshleman SH.

AIDS. 2010 Feb 20;24(4):557-61. doi: 10.1097/QAD.0b013e3283346e60.

PMID:
20057308
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Persistence of nevirapine in breast milk and plasma of mothers and their children after single-dose administration.

Kunz A, Frank M, Mugenyi K, Kabasinguzi R, Weidenhammer A, Kurowski M, Kloft C, Harms G.

J Antimicrob Chemother. 2009 Jan;63(1):170-7. doi: 10.1093/jac/dkn441. Epub 2008 Oct 30.

PMID:
18974161
[PubMed - indexed for MEDLINE]
Free Article
5.

Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.

Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, Kinuthia J, Njiri F, John-Stewart GC.

Antivir Ther. 2008;13(6):799-807.

PMID:
18839781
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

PMID:
18197758
[PubMed - indexed for MEDLINE]
Free Article
7.

Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine.

Lee EJ, Kantor R, Zijenah L, Sheldon W, Emel L, Mateta P, Johnston E, Wells J, Shetty AK, Coovadia H, Maldonado Y, Jones SA, Mofenson LM, Contag CH, Bassett M, Katzenstein DA; HIVNET 023 Study Team.

J Infect Dis. 2005 Oct 1;192(7):1260-4. Epub 2005 Aug 23.

PMID:
16136470
[PubMed - indexed for MEDLINE]
Free Article
8.

Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.

Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, John-Stewart GC.

AIDS. 2005 Sep 2;19(13):1415-22.

PMID:
16103773
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Impact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected children.

Chaix ML, Ekouevi DK, Peytavin G, Rouet F, Tonwe-Gold B, Viho I, Bequet L, Amani-Bosse C, Menan H, Leroy V, Rouzioux C, Dabis F.

Antimicrob Agents Chemother. 2007 Mar;51(3):896-901. Epub 2006 Dec 18.

PMID:
17178792
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.

Moorthy A, Gupta A, Bhosale R, Tripathy S, Sastry J, Kulkarni S, Thakar M, Bharadwaj R, Kagal A, Bhore AV, Patil S, Kulkarni V, Venkataramani V, Balasubramaniam U, Suryavanshi N, Ziemniak C, Gupte N, Bollinger R, Persaud D.

PLoS One. 2009;4(1):e4096. doi: 10.1371/journal.pone.0004096. Epub 2009 Jan 1.

PMID:
19119321
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission.

Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, Njiri F, John-Stewart GC.

J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):472-8.

PMID:
18077838
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.

Pilger D, Hauser A, Kuecherer C, Mugenyi K, Kabasinguzi R, Somogyi S, Harms G, Kunz A.

Antivir Ther. 2011;16(1):109-13. doi: 10.3851/IMP1698.

PMID:
21311114
[PubMed - indexed for MEDLINE]
13.

Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.

TEmAA ANRS 12109 Study group, Arrivé E, Chaix ML, Nerrienet E, Blanche S, Rouzioux C, Coffie PA, Kruy Leang S, McIntyre J, Avit D, Srey VH, Gray G, N'Dri-Yoman T, Diallo A, Ekouévi DK, Dabis F.

AIDS. 2009 Apr 27;23(7):825-33. doi: 10.1097/QAD.0b013e32832949d5.

PMID:
19307941
[PubMed - indexed for MEDLINE]
14.

Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.

Giuliano M, Guidotti G, Andreotti M, Pirillo MF, Villani P, Liotta G, Marazzi MC, Mancini MG, Cusato M, Germano P, Loureiro S, Ceffa S, Regazzi M, Vella S, Palombi L.

J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):286-91.

PMID:
17146372
[PubMed - indexed for MEDLINE]
15.

Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.

Frank M, von Kleist M, Kunz A, Harms G, Schütte C, Kloft C.

Antimicrob Agents Chemother. 2011 Dec;55(12):5529-40. doi: 10.1128/AAC.00741-11. Epub 2011 Sep 26.

PMID:
21947390
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

Jackson JB, Becker-Pergola G, Guay LA, Musoke P, Mracna M, Fowler MG, Mofenson LM, Mirochnick M, Mmiro F, Eshleman SH.

AIDS. 2000 Jul 28;14(11):F111-5.

PMID:
10983633
[PubMed - indexed for MEDLINE]
17.

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.

PLoS Med. 2007 Aug;4(8):e257.

PMID:
17713983
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.

Taha TE, Kumwenda NI, Hoover DR, Fiscus SA, Kafulafula G, Nkhoma C, Nour S, Chen S, Liomba G, Miotti PG, Broadhead RL.

JAMA. 2004 Jul 14;292(2):202-9.

PMID:
15249569
[PubMed - indexed for MEDLINE]
19.

In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.

Church JD, Mwatha A, Bagenda D, Omer SB, Donnell D, Musoke P, Nakabiito C, Eure C, Bakaki P, Matovu F, Thigpen MC, Guay LA, McConnell M, Fowler MG, Jackson JB, Eshleman SH.

AIDS Res Hum Retroviruses. 2009 Jul;25(7):673-7. doi: 10.1089/aid.2009.0003.

PMID:
19552593
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Population pharmacokinetic analysis of a nevirapine-based HIV-1 prevention of mother-to-child transmission program in Uganda to assess the impact of different dosing regimens for newborns.

Frank M, Harms G, Kunz A, Kloft C.

J Clin Pharmacol. 2013 Mar;53(3):294-304. doi: 10.1177/0091270012448397. Epub 2013 Jan 24.

PMID:
23444284
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk